Stockreport

Daiichi Sankyo and GENESIS Pharma Enter Exclusive Agreement for VANFLYTA® Commercialization in Central and Eastern Europe [Yahoo! Finance]

DAIICHI SANKYO S/ADR  (DSNKY) 
PDF MUNICH, January 07, 2026 BUSINESS WIRE )--Daiichi Sankyo (TSE: 4568) and GENESIS Pharma have entered into an exclusive license and supply agreement for the distribution [Read more]